269 related articles for article (PubMed ID: 25279461)
1. A miRNA signature for defining aggressive phenotype and prognosis in gliomas.
Barbano R; Palumbo O; Pasculli B; Galasso M; Volinia S; D'Angelo V; Icolaro N; Coco M; Dimitri L; Graziano P; Copetti M; Valori VM; Maiello E; Carella M; Fazio VM; Parrella P
PLoS One; 2014; 9(10):e108950. PubMed ID: 25279461
[TBL] [Abstract][Full Text] [Related]
2. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
3. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma.
Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y
Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539
[TBL] [Abstract][Full Text] [Related]
4. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
[TBL] [Abstract][Full Text] [Related]
5. miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells.
Kim J; Park MW; Park YJ; Ahn JW; Sim JM; Kim S; Heo J; Jeong JH; Lee M; Lim J; Moon JS
Genes (Basel); 2021 Apr; 12(5):. PubMed ID: 33922649
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 5-Signature Predicting Survival of Patients with Lower-Grade Glioma.
Xiao H; Bai J; Yan M; Ji K; Tian W; Liu D; Ning T; Liu X; Zou J
World Neurosurg; 2019 Jun; 126():e765-e772. PubMed ID: 30853516
[TBL] [Abstract][Full Text] [Related]
7. Profiling of novel circulating microRNAs as a non-invasive biomarker in diagnosis and follow-up of high and low-grade gliomas.
Tabibkhooei A; Izadpanahi M; Arab A; Zare-Mirzaei A; Minaeian S; Rostami A; Mohsenian A
Clin Neurol Neurosurg; 2020 Mar; 190():105652. PubMed ID: 31896490
[TBL] [Abstract][Full Text] [Related]
8. Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma.
Nayak S; Aich M; Kumar A; Sengupta S; Bajad P; Dhapola P; Paul D; Narta K; Purkrait S; Mehani B; Suri A; Chakraborty D; Mukhopadhyay A; Sarkar C
Sci Rep; 2018 May; 8(1):7673. PubMed ID: 29769662
[TBL] [Abstract][Full Text] [Related]
9. MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.
Hermansen SK; Dahlrot RH; Nielsen BS; Hansen S; Kristensen BW
J Neurooncol; 2013 Jan; 111(1):71-81. PubMed ID: 23104517
[TBL] [Abstract][Full Text] [Related]
10. MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.
Delic S; Lottmann N; Stelzl A; Liesenberg F; Wolter M; Götze S; Zapatka M; Shiio Y; Sabel MC; Felsberg J; Reifenberger G; Riemenschneider MJ
Neuro Oncol; 2014 Jan; 16(2):179-90. PubMed ID: 24305703
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.
Nikolova E; Georgiev C; Laleva L; Milev M; Spiriev T; Stoyanov S; Taseva-Mineva T; Mitev V; Todorova A
Mol Genet Genomics; 2022 Mar; 297(2):357-371. PubMed ID: 35064290
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.
Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T
Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048
[TBL] [Abstract][Full Text] [Related]
14. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas.
Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X
J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of miR-378 correlates with tumor invasiveness and poor prognosis of patients with glioma.
Li B; Wang Y; Li S; He H; Sun F; Wang C; Lu Y; Wang X; Tao B
Int J Clin Exp Pathol; 2015; 8(6):7016-21. PubMed ID: 26261592
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
[TBL] [Abstract][Full Text] [Related]
18. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
19. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
